These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 10651657

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Is mycophenolate mofetil an effective alternative in azathioprine-intolerant patients with chronic active Crohn's disease?
    Miehsler W, Reinisch W, Moser G, Gangl A, Vogelsang H.
    Am J Gastroenterol; 2001 Mar; 96(3):782-7. PubMed ID: 11280551
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Mycophenolate mofetil therapy for refractory inflammatory bowel disease.
    Palaniappan S, Ford AC, Greer D, Everett SM, Chalmers DM, Axon AT, Hamlin PJ.
    Inflamm Bowel Dis; 2007 Dec; 13(12):1488-92. PubMed ID: 17924566
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Randomised trial of mycophenolate mofetil versus azathioprine for treatment of chronic active Crohn's disease.
    Neurath MF, Wanitschke R, Peters M, Krummenauer F, Meyer zum Büschenfelde KH, Schlaak JF.
    Gut; 1999 May; 44(5):625-8. PubMed ID: 10205197
    [Abstract] [Full Text] [Related]

  • 8. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M.
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [Abstract] [Full Text] [Related]

  • 9. Real-world use of mycophenolate mofetil in inflammatory bowel disease: Results from the ENEIDA registry.
    Hernández-Camba A, Arranz L, Vera I, Carpio D, Calafat M, Lucendo AJ, Taxonera C, Marín S, Garcia MJ, Marín GS, Rodríguez ES, Carbajo AY, De Castro ML, Iborra M, Martin-Cardona A, Rodríguez-Lago I, Busquets D, Bertoletti F, Ausín MS, Tardillo C, Malaves JH, Bujanda L, Castaño A, Domènech E, Ramos L, GETECCU (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa), Additional member of the Spanish GETECCU group.
    Dig Liver Dis; 2022 May; 54(5):635-641. PubMed ID: 34862115
    [Abstract] [Full Text] [Related]

  • 10. Toxicity of mycophenolate mofetil in patients with inflammatory bowel disease.
    Skelly MM, Logan RF, Jenkins D, Mahida YR, Hawkey CJ.
    Inflamm Bowel Dis; 2002 Mar; 8(2):93-7. PubMed ID: 11854606
    [Abstract] [Full Text] [Related]

  • 11. [Mycophenolate mofetil in refractory Crohn's disease after failure of treatments by azathioprine or methotrexate].
    Hafraoui S, Dewit O, Marteau P, Cosnes J, Colombel JF, Modigliani R, Cortot A, Lémann M.
    Gastroenterol Clin Biol; 2002 Jan; 26(1):17-22. PubMed ID: 11938035
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Mycophenolate mofetil in patients with Crohn's disease.
    Fickert P, Hinterleitner TA, Wenzl HH, Aichbichler BW, Petritsch W.
    Am J Gastroenterol; 1998 Dec; 93(12):2529-32. PubMed ID: 9860419
    [Abstract] [Full Text] [Related]

  • 14. [Mycophenolate mofetil in the treatment of primary nephrotic syndrome].
    Zhao M, Chen X, Chen Y, Liu Z, Liu Y, Lu F, Zhang Y, Wang H.
    Zhonghua Yi Xue Za Zhi; 2001 May 10; 81(9):528-31. PubMed ID: 11809115
    [Abstract] [Full Text] [Related]

  • 15. Treatment of steroid refractory inflammatory bowel disease (IBD) with mycophenolate mofetil (MMF).
    Florin TH, Roberts RK, Watson MR, Radford-Smith GL.
    Aust N Z J Med; 1998 Jun 10; 28(3):344-5. PubMed ID: 9673748
    [No Abstract] [Full Text] [Related]

  • 16. Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis.
    Ginzler EM, Dooley MA, Aranow C, Kim MY, Buyon J, Merrill JT, Petri M, Gilkeson GS, Wallace DJ, Weisman MH, Appel GB.
    N Engl J Med; 2005 Nov 24; 353(21):2219-28. PubMed ID: 16306519
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mycophenolate mofetil in refractory inflammatory bowel disease.
    Ford AC, Towler RJ, Moayyedi P, Chalmers DM, Axon AT.
    Aliment Pharmacol Ther; 2003 Jun 01; 17(11):1365-9. PubMed ID: 12786630
    [Abstract] [Full Text] [Related]

  • 19. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
    Kwinta-Rybicka J, Wilkosz K, Wierzchowska-Słowiacze EK, Ogarek I, Moczulska A, Stec Z, Pełkowska A, Sancewicz-Pach K, Pietrzyk JA.
    Przegl Lek; 2006 Jun 01; 63 Suppl 3():44-8. PubMed ID: 16898486
    [Abstract] [Full Text] [Related]

  • 20. Mycophenolate Mofetil Combined With Prednisone Versus Full-Dose Prednisone in IgA Nephropathy With Active Proliferative Lesions: A Randomized Controlled Trial.
    Hou JH, Le WB, Chen N, Wang WM, Liu ZS, Liu D, Chen JH, Tian J, Fu P, Hu ZX, Zeng CH, Liang SS, Zhou ML, Zhang HT, Liu ZH.
    Am J Kidney Dis; 2017 Jun 01; 69(6):788-795. PubMed ID: 28215945
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.